Min Wu

Min Wu currently serves as the Vice President of Biology, bringing a robust educational and professional background to her role. She earned a Ph.D. in Biomedical Sciences from the collaborative program between Oak Ridge National Lab and the University of Tennessee. Following this, she completed her postdoctoral training at the prestigious Whitehead Institute of MIT. Min Wu has held significant positions in the biopharmaceutical industry, including as the Senior Director of Biology at Proteostasis Therapeutics. During her tenure, she led a multi-year collaboration with Astellas Pharma, focusing on the discovery and early development of a small molecule therapeutic aimed at treating a rare genetic liver disease. Additionally, she has overseen multiple small molecule programs targeting genetic diseases that affect the proteostasis network. Her career also includes roles with increasing responsibilities in discovery biology, pharmacology, biomarker development, and translational research at notable organizations such as FORMA Therapeutics, Agios Pharmaceuticals, and AVEO Oncology.